JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB9202

Anti-Dengue Envelope antibody [D1-11(3)]

Be the first to review this product! Submit a review

|

(11 Publications)

Mouse Monoclonal POLG antibody. Suitable for I-ELISA, ELISA, Dot, WB and reacts with Dengue virus 1, Dengue virus 2, Dengue virus 3 samples. Cited in 11 publications.

View Alternative Names

Genome polyprotein, Genome polyprotein, pol, Capsid Protein, Dengue hemorrhagic fever, DENV-3

1 Images
Indirect ELISA - Anti-Dengue Envelope antibody [D1-11(3)] (AB9202)
  • I-ELISA

Supplier Data

Indirect ELISA - Anti-Dengue Envelope antibody [D1-11(3)] (AB9202)

Indirect ELISA Purified Mouse anti-Dengue Envelope (Clone #D1-11) (ab9202). Antigen- 500 ng/well. Incubated 60 minutes. Primary Antibody. Incubated 60 minutes. Secondary, HRP Goat-Anti Mouse IgG2a. Developed with TMB (10 minutes). Microplate reader set at 450nm.

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

D1-11(3)

Isotype

IgG2a

Light chain type

kappa

Carrier free

No

Reacts with

Dengue virus 1, Dengue virus 2, Dengue virus 3

Applications

Dot, I-ELISA, WB, ELISA

applications

Specificity

This antibody reacts with dengue virus type 1,2, and 3 as determined by blotting assays, ELISA and IF techniques.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IELISA" : {"fullname" : "Indirect ELISA", "shortname":"I-ELISA"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "Dot" : {"fullname" : "Dot Blot", "shortname":"Dot"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Dengue virus 1": { "IELISA-species-checked": "testedAndGuaranteed", "IELISA-species-dilution-info": "", "IELISA-species-notes": "<p></p>", "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p>Please note that the reactivity of this antibody varies between strains and various isolates, therefore, a single dilution may not be appropriate for each situation.</p>" }, "Dengue virus 2": { "IELISA-species-checked": "predicted", "IELISA-species-dilution-info": "", "IELISA-species-notes": "", "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p>Please note that the reactivity of this antibody varies between strains and various isolates, therefore, a single dilution may not be appropriate for each situation.</p>" }, "Dengue virus 3": { "IELISA-species-checked": "predicted", "IELISA-species-dilution-info": "", "IELISA-species-notes": "", "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "Dot-species-checked": "guaranteed", "Dot-species-dilution-info": "", "Dot-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p>Please note that the reactivity of this antibody varies between strains and various isolates, therefore, a single dilution may not be appropriate for each situation.</p>" } } }

Product details

The myeloma cell line used as a fusion partner produces small amounts of IgG1, therefore IgG1 is sometimes present in the preparation.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Purification notes
All hybridoma proteins are produced from tissue culture and purified using Protein A- affinity chromatography.
Storage buffer
pH: 7.2 Preservative: 0.09% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Dengue Virus commonly known as DENV includes four serotypes: DENV-1 DENV-2 DENV-3 and DENV-4. Each serotype comprises a complex structure with a viral envelope containing the structural proteins envelope (E) and membrane (M) among others. The envelope protein is key for entry into host cells by mediating binding and fusion. The non-structural proteins such as NS3 and NS5 are involved in viral replication and assembly. The virus circulates across tropical and subtropical regions primarily transmitted by Aedes aegypti mosquitoes.
Biological function summary

Dengue Virus impacts human cells by initiating a series of interactions once it enters the blood system. It hijacks the host's cellular machinery to replicate and generate viral particles. It triggers immune responses leading to production of antibodies such as anti-Dengue antibodies. The virus does not operate alone but within a complex involving the host immune response influencing cell signaling pathways.

Pathways

Dengue Virus is integrated into the type I interferon signaling pathway and the TLR3 signaling pathway. These pathways trigger antiviral responses that attempt to limit viral replication. The virus interacts with host proteins including STAT1 and IRF3 which play roles in these pathways. The virus evades the immune response by modifying these pathways enhancing its survival and replication in the host.

Dengue Virus is connected to Dengue Fever and Dengue Hemorrhagic Fever which can lead to severe complications and even death. It modulates host proteins involving cytokines like TNF-alpha and interleukins contributing to pathogenesis and immune system breakdown. Understanding the virus’s interaction with these proteins is essential in the development of vaccines and therapeutic antibodies targeting Dengue infections.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Capsid protein C. Capsid protein C self-assembles to form an icosahedral capsid about 30 nm in diameter. The capsid encapsulates the genomic RNA (Probable). Plays a role in virus budding by binding to the cell membrane and gathering the viral RNA into a nucleocapsid that forms the core of a mature virus particle. During virus entry, may induce genome penetration into the host cytoplasm after hemifusion induced by the surface proteins. Can migrate to the cell nucleus where it modulates host functions. Overcomes the anti-viral effects of host EXOC1 by sequestering and degrading the latter through the proteasome degradation pathway (PubMed : 23522008).. Peptide pr. Prevents premature fusion activity of envelope proteins in trans-Golgi by binding to envelope protein E at pH6.0. After virion release in extracellular space, gets dissociated from E dimers.. Protein prM. Acts as a chaperone for envelope protein E during intracellular virion assembly by masking and inactivating envelope protein E fusion loop. prM is the only viral peptide matured by host furin in the trans-Golgi network probably to avoid catastrophic activation of the viral fusion activity in acidic Golgi compartment prior to virion release. prM-E cleavage is inefficient, and many virions are only partially matured. These uncleaved prM would play a role in immune evasion.. Small envelope protein M. May play a role in virus budding. Exerts cytotoxic effects by activating a mitochondrial apoptotic pathway through M ectodomain. May display a viroporin activity.. Envelope protein E. Type II fusion protein that binds to host cell surface receptor and mediates fusion between viral and cellular membranes (Probable). The envelope protein E shifts from dimeric state to trimeric state to perform fusion with the host membrane (By similarity). The fusion loops of the three subunits come together to form a membrane-insertable tip containing aromatic residues (By similarity). Envelope protein is synthesized in the endoplasmic reticulum in the form of heterodimer with protein prM. They play a role in virion budding in the ER, and the newly formed immature particle is covered with 60 spikes composed of heterodimers of precursor prM and envelope protein E (By similarity). Envelope protein exposes a positively-charged pr-binding pocket at the E dimer interface, inducing (prM/E)2 dimer formation to generate smooth particles in the Golgi (By similarity). The virion is transported to the Golgi apparatus where the low pH causes dissociation of PrM-E heterodimers and formation of E homodimers (By similarity). prM-E cleavage is inefficient, and many virions are only partially matured. These uncleaved prM would play a role in immune evasion (By similarity). Pr is shed from the particle upon subsequent secretion into the extracellular environment, leaving an activated particle, prone to mediate acidic pH-triggered membrane fusion upon entry into a target cell (By similarity).. Non-structural protein 1. Involved in immune evasion, pathogenesis and viral replication. Once cleaved off the polyprotein, is targeted to three destinations : the viral replication cycle, the plasma membrane and the extracellular compartment. Essential for viral replication. Required for formation of the replication complex and recruitment of other non-structural proteins to the ER-derived membrane structures. Excreted as a hexameric lipoparticle that plays a role against host immune response. Antagonizing the complement function. Binds to the host macrophages and dendritic cells. Inhibits signal transduction originating from Toll-like receptor 3 (TLR3).. Non-structural protein 1. Involved in immune evasion, pathogenesis and viral replication. Once cleaved off the polyprotein, is targeted to three destinations : the viral replication cycle, the plasma membrane and the extracellular compartment. Essential for viral replication. Required for formation of the replication complex and recruitment of other non-structural proteins to the ER-derived membrane structures. Excreted as a hexameric lipoparticle that plays a role against host immune response. Antagonizing the complement function. Binds to the host macrophages and dendritic cells. Inhibits signal transduction originating from Toll-like receptor 3 (TLR3) (By similarity). Mediates complement activation, which may contribute to the pathogenesis of the vascular leakage that occurs in severe dengue disease (PubMed : 16544248). Activates autophagy through the AMPK/ERK/mTOR signaling pathway. Mechanistically, acts as the assembly platform for STK11-AMPK interactions and promotes STK11-AMPK interactions. In turn, promotes phosphorylation of the AMPK kinase structural domain and activates AMPK, thereby positively regulating the AMPK/ERK/mTOR signaling pathway and inducing autophagy (PubMed : 37821951).. Non-structural protein 2A. Component of the viral RNA replication complex that functions in virion assembly and antagonizes the host immune response.. Serine protease subunit NS2B. Required cofactor for the serine protease function of NS3. May have membrane-destabilizing activity and form viroporins (By similarity).. Serine protease NS3. Displays three enzymatic activities : serine protease, NTPase and RNA helicase. NS3 serine protease, in association with NS2B, performs its autocleavage and cleaves the polyprotein at dibasic sites in the cytoplasm : C-prM, NS2A-NS2B, NS2B-NS3, NS3-NS4A, NS4A-2K and NS4B-NS5. NS3 RNA helicase binds RNA and unwinds dsRNA in the 3' to 5' direction.. Non-structural protein 4A. Regulates the ATPase activity of the NS3 helicase activity. NS4A allows NS3 helicase to conserve energy during unwinding. Plays a role in the inhibition of the host innate immune response. Interacts with host MAVS and thereby prevents the interaction between RIGI and MAVS. In turn, IFN-beta production is impaired. Interacts with host AUP1 which mediates induction of lipophagy in host cells and facilitates production of virus progeny particles (By similarity).. Peptide 2k. Functions as a signal peptide for NS4B and is required for the interferon antagonism activity of the latter.. Non-structural protein 4B. Induces the formation of ER-derived membrane vesicles where the viral replication takes place. Inhibits interferon (IFN)-induced host STAT1 phosphorylation and nuclear translocation, thereby preventing the establishment of cellular antiviral state by blocking the IFN-alpha/beta pathway (PubMed : 15956546).. RNA-directed RNA polymerase/Methyltransferase NS5. Replicates the viral (+) and (-) RNA genome, and performs the capping of genomes in the cytoplasm (By similarity). NS5 methylates viral RNA cap at guanine N-7 and ribose 2'-O positions (PubMed : 19850911). Besides its role in RNA genome replication, also prevents the establishment of cellular antiviral state by blocking the interferon-alpha/beta (IFN-alpha/beta) signaling pathway (PubMed : 15944325). Inhibits host TYK2 and STAT2 phosphorylation, thereby preventing activation of JAK-STAT signaling pathway (PubMed : 19754307). May reduce immune responses by preventing the recruitment of the host PAF1 complex to interferon-responsive genes (PubMed : 30550790).
See full target information Dengue virus Envelope protein

Additional targets

,Dengue virus 3,pol

Publications (11)

Recent publications for all applications. Explore the full list and refine your search

Journal of nanobiotechnology 23:221 PubMed40102899

2025

The immunogenic potential of an optimized mRNA lipid nanoparticle formulation carrying sequences from virus and protozoan antigens.

Applications

Unspecified application

Species

Unspecified reactive species

Renata S Fernandes,Gabriela de Assis Burle-Caldas,Sarah Aparecida Rodrigues Sergio,Ana Flávia Bráz,Nathália Pereira da Silva Leite,Milton Pereira,Juliana de Oliveira Silva,Natália Satchiko Hojo-Souza,Bianca de Oliveira,Ana Paula S Moura Fernandes,Flávio Guimarães da Fonseca,Ricardo Tostes Gazzinelli,Diego Dos Santos Ferreira,Santuza M Ribeiro Teixeira

Journal of medical virology 96:e29895 PubMed39228306

2024

Pathogenicity and transcriptomic resolution in dengue virus serotype 1 infected AGB6 mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Ning Yu,Shigang Chen,Yumeng Liu,Peng Wang,Longlong Wang,Ningning Hu,He Zhang,Xiao Li,Huijun Lu,Ningyi Jin

Journal of medical virology 93:3362-3373 PubMed33219544

2020

Mosquito-infecting virus Espirito Santo virus inhibits replication and spread of dengue virus.

Applications

Unspecified application

Species

Unspecified reactive species

Avian V White,Ming Fan,Jordan M Mazzara,Rachel L Roper,Stephanie L Richards

Scientific reports 10:11302 PubMed32647259

2020

Nanosensors based on LSPR are able to serologically differentiate dengue from Zika infections.

Applications

Unspecified application

Species

Unspecified reactive species

Alice F Versiani,Estefânia M N Martins,Lidia M Andrade,Laura Cox,Glauco C Pereira,Edel F Barbosa-Stancioli,Mauricio L Nogueira,Luiz O Ladeira,Flávio G da Fonseca

Molecular therapy. Nucleic acids 19:1460-1469 PubMed32160714

2020

CRISPR-Cas13a Cleavage of Dengue Virus NS3 Gene Efficiently Inhibits Viral Replication.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Li,Shan Wang,Xue Dong,Qiao Li,Min Li,Junfeng Li,Yan Guo,Xia Jin,Yusen Zhou,Hongbin Song,Zhihua Kou

Frontiers in cellular and infection microbiology 9:284 PubMed31456950

2019

Dengue Non-structural Protein 5 Polymerase Complexes With Promyelocytic Leukemia Protein (PML) Isoforms III and IV to Disrupt PML-Nuclear Bodies in Infected Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Federico Giovannoni,María Fatima Ladelfa,Martin Monte,David A Jans,Peter Hemmerich,Cybele García

Scientific reports 7:5816 PubMed28725041

2017

A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound.

Applications

IF

Species

Unspecified reactive species

Abhilasha Madhvi,Smita Hingane,Rajpal Srivastav,Nishant Joshi,Chandru Subramani,Rajagopalan Muthumohan,Renu Khasa,Shweta Varshney,Manjula Kalia,Sudhanshu Vrati,Milan Surjit,C T Ranjith-Kumar

Journal of applied microbiology 119:1170-80 PubMed26248692

2015

Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.

Applications

Unspecified application

Species

Unspecified reactive species

M-F Chew,H-W Tham,M Rajik,S H Sharifah

PloS one 10:e0125690 PubMed25962098

2015

Cellular promyelocytic leukemia protein is an important dengue virus restriction factor.

Applications

IF

Species

Unspecified reactive species

Federico Giovannoni,Elsa B Damonte,Cybele C García

PloS one 7:e44835 PubMed22970315

2012

Differential requirements in endocytic trafficking for penetration of dengue virus.

Applications

Unspecified application

Species

Unspecified reactive species

Eliana G Acosta,Viviana Castilla,Elsa B Damonte
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com